Condition
Menorrhagia Due to Benign Causes
Total Trials
4
Recruiting
1
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
3 of 3 completed with results
Key Signals
3 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed3
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07557992RecruitingPrimary
Reframing Endometrial Physiology by Advanced Integrated Research
NCT02029911Not ApplicableCompletedPrimary
A Multi-Center, Single Arm Clinical Study of the Safety and Efficacy of the AURORA™ Endometrial Ablation System
NCT02023801Not ApplicableCompletedPrimary
A Single Arm Clinical Study of the Safety and Efficacy of the AURORA™ Endometrial Ablation System
NCT02035332Not ApplicableCompletedPrimary
A Two-Phase Clinical Study of the Minerva AURORA Ablation System
Showing all 4 trials